[go: up one dir, main page]

SU1438434A1 - Method of assay of thymus hormone activity - Google Patents

Method of assay of thymus hormone activity

Info

Publication number
SU1438434A1
SU1438434A1 SU4067891/14A SU4067891A SU1438434A1 SU 1438434 A1 SU1438434 A1 SU 1438434A1 SU 4067891/14 A SU4067891/14 A SU 4067891/14A SU 4067891 A SU4067891 A SU 4067891A SU 1438434 A1 SU1438434 A1 SU 1438434A1
Authority
SU
USSR - Soviet Union
Prior art keywords
assay
hormone activity
incubated
activity
thymus hormone
Prior art date
Application number
SU4067891/14A
Other languages
Russian (ru)
Inventor
Н.С. Мотавкина
Н.Б. Сандлер
Original Assignee
Владивостокский государственный медицинский институт
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Владивостокский государственный медицинский институт filed Critical Владивостокский государственный медицинский институт
Priority to SU4067891/14A priority Critical patent/SU1438434A1/en
Application granted granted Critical
Publication of SU1438434A1 publication Critical patent/SU1438434A1/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

FIELD: immunology. SUBSTANCE: thymocyte suspension and solution of thymus hormone were incubated. To this mixture human erythrocytes of 0(1) blood group were added, monolayer is formed and incubated. Quantity of hemolytic plaques is counted. One unit of hormone activity is determined as its quantity that increases killer activity by 50% as compared with that of control value. Method ensures to correct medicinal dose. EFFECT: increased precise of method.
SU4067891/14A 1986-03-07 1986-03-07 Method of assay of thymus hormone activity SU1438434A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
SU4067891/14A SU1438434A1 (en) 1986-03-07 1986-03-07 Method of assay of thymus hormone activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU4067891/14A SU1438434A1 (en) 1986-03-07 1986-03-07 Method of assay of thymus hormone activity

Publications (1)

Publication Number Publication Date
SU1438434A1 true SU1438434A1 (en) 1996-03-20

Family

ID=60534354

Family Applications (1)

Application Number Title Priority Date Filing Date
SU4067891/14A SU1438434A1 (en) 1986-03-07 1986-03-07 Method of assay of thymus hormone activity

Country Status (1)

Country Link
SU (1) SU1438434A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216020C2 (en) * 1996-09-03 2003-11-10 Рисерч Дивелопмент Фаундейшн Determination of intracellular concentrations of cysteine and glutathione

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2216020C2 (en) * 1996-09-03 2003-11-10 Рисерч Дивелопмент Фаундейшн Determination of intracellular concentrations of cysteine and glutathione

Similar Documents

Publication Publication Date Title
BG60261B2 (en) Lon-acting formulation of cefaclor
ES2137948T3 (en) ADVANCED SYSTEM OF ADMINISTRATION OF MEDICINES AND METHOD OF TREATMENT OF PSYCHIATRIC, NEUROLOGICAL AND OTHER DISORDERS WITH CARBAMACEPINE.
EP0151989A3 (en) Means for the treatment of cardiac diseases
EP0067130A3 (en) Capsules containing the active principle of an allergen, and process for their preparation
ES8308211A1 (en) Pharmaceutical mixture.
SE9301290D0 (en) USE OF A SOMATOSTATIN ANALOGUE
ES8102141A1 (en) 3,7-Disubstituted-3-cephem-4-carboxylic acid compounds
DE3650358D1 (en) Pharmaceutical compositions containing diphosphonates for the treatment of arthrosis.
Taylor‐Robinson Inhibition of IL‐2 production by nitric oxide: A novel self‐regulatory mechanism for Th1 cell proliferation
MY106231A (en) Antiviral tetrahydroimidazo [1,4] benzodiazepin-2- thiones.
JO1589B1 (en) Antiviral tetrahydroimidazo(1,4)benzodiazepin-2-ones
DE3750235D1 (en) Treatment of autoimmune diseases with immuno-reinforcing substances.
Christodoulopoulos et al. Action of secretin on pancreatic secretion
ATE65912T1 (en) MEDICINAL COMPOSITIONS OF REDUCED TOXICITY.
Gilbert The effect of oestrogen and thyroxine on the blood volume of the domestic cock
SU1438434A1 (en) Method of assay of thymus hormone activity
Harbers et al. Effect of barbituric acid and chlortetracycline upon growth, ammonia concentration, and urease activity in the gastrointestinal tract of chicks
ES8304058A1 (en) 3,7,11,15-Tetramethyl- 2,4,6,10,14-hexadecapentaenoic Acid
JPS6434252A (en) Feed blended with crude drug for fish and shellfish
ATE66375T1 (en) USE OF INTERFERON-GAMMA (IFN-GAMMA) CONTAINING PREPARATIONS FOR THE SYSTEMIC TREATMENT OF VARIOUS HUMAN DISEASES AT LOW DOSES.
Kohl Stimulation of human natural killer cytotoxicity and protection of mice from infection due to herpes simplex virus by recombinant human leukocyte interferon
SU1326744A1 (en) Method of activating phagocytosis of makrophages in vitro
Lorscheider et al. EFFECTS OF EXTENDED LACTATION AND 9α-FLUOROPREDNISOLONE ACETATE ON SERUM THYROXINE AND LACTATIONAL PERFORMANCE
SU1517173A1 (en) Antiseptic agent
HU9201976D0 (en) Medical preparative inhibiting production of active lymphocytes